TB-500 Peptide: Research Overview

TB-500 is the synthetic analogue of Thymosin Beta-4 (Tβ4), a 43-amino acid protein originally isolated from bovine thymus tissue. The specific fragment used in research — typically the central actin-binding domain sequence Ac-LKKTETQ — exhibits high affinity for G-actin monomers and has been studied extensively in models of tissue repair, wound healing, and inflammation modulation. This overview summarizes current research findings and key considerations for laboratory use.

Structure and Actin-Binding Properties

Thymosin Beta-4 belongs to the beta-thymosin family of small acidic peptides that regulate actin polymerization. The peptide's core tetrapeptide motif LKKTET binds monomeric actin (G-actin), preventing its incorporation into filamentous actin (F-actin). This regulation of actin dynamics is central to cytoskeletal remodeling processes, which underlie cell migration — a critical early step in wound closure and tissue regeneration models. TB-500 has a molecular weight of approximately 4963 Da when synthesized as the full Tβ4 sequence.

Preclinical Study Models

TB-500 has been studied in multiple preclinical contexts. In dermal wound models, researchers have documented accelerated re-epithelialization and increased laminin-5 and collagen IV expression at wound margins. Cardiac ischemia models have explored whether Tβ4 promotes cardiomyocyte survival and vessel remodeling following experimental MI. Separately, ocular surface research has examined its role in corneal repair and dry-eye models, with some studies noting modulation of MMP-2 activity. In neurological model work, Tβ4 has been studied in the context of oligodendrocyte differentiation and remyelination signaling.

Anti-Inflammatory Signaling

Beyond direct actin regulation, TB-500 research has identified downstream effects on inflammatory mediator expression. Studies in macrophage culture models report downregulation of NF-κB-dependent cytokine output (IL-1β, TNF-α) following Tβ4 treatment. The peptide has also been linked to upregulation of anti-inflammatory mediators including IL-10 in specific tissue contexts. Researchers should be aware that these effects are model-specific and dose-dependent — extrapolation across tissue types requires independent verification.

Research Purity and Protocol Notes

Batch purity is a particularly sensitive variable for TB-500 research. Sequence truncations or acetylation errors during synthesis can alter binding affinity meaningfully. Researchers should confirm HPLC purity of ≥98% and request MS identity confirmation (expected m/z matching the theoretical mass of the synthesized fragment) before incorporating any lot into a protocol. Lyophilized TB-500 should be stored at −20°C and reconstituted with bacteriostatic water at the time of use.

PeptoBuy supplies research-grade TB-500 (10 mg lyophilized, ≥98% purity) for qualified laboratories. COA with HPLC and MS data is available on request for every batch. For in vitro research use only — not for human or animal consumption.